DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer
Year: 2017
Type: article
Study design: Observational Study
Abstract: BACKGROUND: We previously identified discoidin-domain receptor 2 (DDR2) as a promising driver gene of peritoneal dissemination (PD) in gastric cancer. In the present study we explored the clinical significance of DDR2 expression in colorectal cancer (CRC). MATERIALS AND METHODS: We examined DDR2 expression in CRC specimens by immunohistochemistry. We analyzed the association of DDR2 expression with clinicopathological factors in CRC. We divided 63 CRC cases into two groups according to their level of DDR2 expression and compared several clinicopathological factors and their overall survival. RESULTS: The group with high DDR2 expression had significantly higher frequencies of T4, lymph node metastasis, and PD compared to the group with low DDR2 expression. Furthermore, the prognosis of the group with high DDR2 expression was significantly poorer than the group with low DDR2. CONCLUSION: DDR2 is a powerful biomarker that can predict poor prognosis as well as PD, and might be an effective therapeutic target for CRC.
Source: Anticancer Research
Institutions: Omori Red Cross Hospital, Kyushu University Beppu Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Novel therapeutic development with the target of cancer cell eradication against cancer stem cells, 大腸癌におけるMYCとの合成致死作用を持つ遺伝子の同定, FOSB and c-Fos which constitute AP-1 expressed in the bone marrow at the advanced gastric cancer patients, 固形癌組織のclonal evolution, heterogeneityの解析, Investigation of intratumoral heterogeneity in intrahepatic cholangiocarcinoma using multiregional analysis and innovative drug target discovery
OpenAlex ID: W2613999727
